XML 46 R7.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Jul. 04, 2015
Jun. 28, 2014
Cash flows from operating activities:    
Net income $ 53,111 $ 121,439
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 63,455 57,299
Stock-based compensation 38,135 37,862
Excess tax benefits from stock-based awards 71 (9,576)
Other non-cash items, net (53) (151)
Changes in operating assets and liabilities, excluding the effects of acquisitions:    
Accounts receivable 44,906 14,625
Accounts payable, accrued expenses and other current liabilities 17,433 (3,930)
Accrued compensation and benefits (27,462) (24,278)
Deferred revenue 51,393 55,339
Accrued and deferred income taxes (25,608) 14,545
Other current assets and prepaid expenses (5,109) 4,125
Other noncurrent assets and liabilities (17,809) (13,912)
Net cash provided by operating activities 192,463 253,387
Cash flows from investing activities:    
Additions to property and equipment (20,637) (16,721)
Purchases of investments (11,000) 0
Acquisitions of businesses, net of cash acquired (98,411) (111,519)
Net cash used by investing activities (130,048) (128,240)
Cash flows from financing activities:    
Borrowings under credit facility 135,000 474,375
Repayments of borrowings under credit facility (122,500) (417,500)
Repurchases of common stock (49,962) (99,915)
Proceeds from issuance of common stock 38 801
Excess tax benefits from stock-based awards (71) 9,576
Credit facility origination costs 0 (4,120)
Payments of withholding taxes in connection with vesting of stock-based awards (29,117) (26,749)
Net cash used by financing activities (66,612) (63,532)
Effect of exchange rate changes on cash and cash equivalents (14,397) 645
Net (decrease) increase in cash and cash equivalents (18,594) 62,260
Cash and cash equivalents, beginning of period 293,654 241,913
Cash and cash equivalents, end of period 275,060 304,173
Supplemental disclosure of non-cash investing activities:    
Fair value of contingent consideration recorded for acquisition $ 3,800 $ 13,993